EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with Diabetes

Sarit Polsky iD, Amy M Valent iD, Elvira Isganaitis iD, Kristin Castorino iD, Grenye O'Malley, Stayce E Beck, Peggy Gao, Lori M Laffel iD, Florence M Brown iD, Carol J Levy iD

Diabetes Technology & Therapeutics · 2024

DOI: 10.1089/dia.2023.0516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2024. Verfasst von Sarit Polsky und 9 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Continuous Glucose Monitoring, Diabetes Mellitus, Type 1, Diabetes, Gestational, Pregnancy in Diabetics. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: We evaluated accuracy and safety of a seventh-generation real-time continuous glucose monitoring (CGM) system during pregnancy. Materials and Methods: Evaluable data for accuracy analysis were obtained from 96 G7 sensors (Dexcom, Inc.) worn by 96 of 105 enrolled pregnant women with type 1 ( n = 59), type 2 ( n = 21), or gestational diabetes ( n = 25). CGM values were compared with arterialized venous glucose values from the YSI comparator instrument during 6-h clinic sessions at different time points throughout the sensors' 10-day wear period. The primary endpoint was the proportion of CGM values in the 70–180 mg/dL range within 15% of comparator glucose values. Secondary endpoints included the proportion of CGM values within 20% or 20 mg/dL of comparator values ≥ or

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Glucose MonitoringDiabetes Mellitus, Type 1Diabetes, GestationalPregnancy in DiabeticsAdultFemaleHumansPregnancyYoung AdultBlood GlucoseDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

Continuous glucose monitoringAccuracyDexcom G7Gestational DiabetesPregnancySafety

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Oregon Health and Science University, Portland, Oregon, USA.
  • Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Sansum Diabetes Research Institute, Santa Barbara, California, USA.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Clinical Affairs, Dexcom, Inc., San Diego, California, USA.

ORCID-Profile: Sarit Polsky, Amy M Valent, Elvira Isganaitis, Kristin Castorino, Lori M Laffel, Florence M Brown, Carol J Levy

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Polsky, S., Valent, A. M., Isganaitis, E., Castorino, K., O'Malley, G., Beck, S. E., Gao, P., Laffel, L. M., Brown, F. M., & Levy, C. J. (2024). Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2023.0516

Vancouver

Polsky S, Valent AM, Isganaitis E, Castorino K, O'Malley G, Beck SE, et al. Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with Diabetes. Diabetes Technology & Therapeutics. 2024. doi:10.1089/dia.2023.0516

BibTeX
@article{Polsky2024,
  author = {Polsky, Sarit and Valent, Amy M and Isganaitis, Elvira and Castorino, Kristin and O'Malley, Grenye and Beck, Stayce E and Gao, Peggy and Laffel, Lori M and Brown, Florence M and Levy, Carol J},
  title = {Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with Diabetes},
  journal = {Diabetes Technology & Therapeutics},
  year = {2024},
  doi = {10.1089/dia.2023.0516}
}
Kostenlos starten →